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PER3 gene polymorphisms have been associated with differences in human sleep-wake phenotypes, 
and sensitivity to light. The aims of this study were to assess: i) the frequency of allelic variants at 
two PER3 polymorphic sites (rs57875989 length polymorphism: PER34, PER35; rs228697 SNP: PER3C, 
PER3G) in relation to sleep-wake timing; ii) the effect of morning light on behavioural/circadian 
variables in PER34/PER34 and PER35/PER35 homozygotes. 786 Caucasian subjects living in Northern 
Italy donated buccal DNA and completed diurnal preference, sleep quality/timing and sleepiness/
mood questionnaires. 19 PER34/PER34 and 11 PER35/PER35 homozygotes underwent morning light 
administration, whilst monitoring sleep-wake patterns and the urinary 6-sulphatoxymelatonin 
(aMT6s) rhythm. No significant relationship was observed between the length polymorphism and 
diurnal preference. By contrast, a significant association was observed between the PER3G variant and 
morningness (OR = 2.10), and between the PER3G-PER34 haplotype and morningness (OR = 2.19), for 
which a mechanistic hypothesis is suggested. No significant differences were observed in sleep timing/
aMT6s rhythms between PER35/PER35 and PER34/PER34 subjects at baseline. After light administration, 
PER34/PER34 subjects advanced their aMT6s acrophase (p < 0.05), and showed a trend of advanced 
sleep-wake timing. In conclusion, significant associations were observed between PER3 polymorphic 
variants/their combinations and both diurnal preference and the response to light.
Clock genes and their products are associated with the current molecular model for the genesis of circadian 
rhythms1. Allelic variants of clock genes affect the period and the phase of circadian rhythms2.
An important component of the biological clock is the Period (PER) gene family. The heterodimers formed by 
PER3 protein with PER1/2 and cryptochrome 1/2 (CRY1/2) enter the nucleus, inhibit CLOCK/BMAL1-mediated 
transcription3, thus contributing to the output pathway of circadian oscillations4. The human PER3 gene shows 
higher levels of polymorphism compared to the other PER paralogs5, suggesting that PER3 may account for indi-
vidual differences in human circadian and sleep phenotypes.
The coding region of the PER3 gene contains a variable-number tandem-repeat (VNTR) polymorphism, i.e. 
a motif encoding 18 amino acids is repeated either four (PER34) or five (PER35) times in exon 186 (rs57875989, 
NM_001289861.1:c.3002-13_3042del54). The repeated unit contains a cluster of putative phosphorylation sites, 
and the polymorphism may influence PER3 function. There is some evidence that, in humans, PER3 may be 
related to diurnal preference, or the personal inclination to be more/less active at different times of the wak-
ing day. The PER34 allelic variant has been associated with physiological and pathological eveningness6, 7 while 
the PER35 allele has been associated with morningness7. In addition, the PER35 allele has been associated with 
enhanced suppression of nocturnal melatonin by administration of light at night8. However, the effect of light in 
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the morning, which is often utilised for treatment purposes (i.e. seasonal affective disorder, delayed sleep-wake 
rhythms, irregular schedules etc.9, 10) has not been tested within this context.
Recently, a SNP (rs228697, NM_001289861.1:c.2590 C> G) in exon 17 of PER3 that causes the amino acid 
substitution P864A has also been associated with diurnal preference11, with the 2590G allele (864 A) being more 
prevalent in evening types. The P864A substitution would disrupt two potential SH3-binding motif domains in 
PER3, most likely altering the binding properties of the protein. The scaffolding protein NCK contains SH3 bind-
ing motifs which could mediate the interactions with PER3 and with the subunit γ2 of Casein Kinase 1 (CK1)12. 
CK1δ and ε are known to regulate PER proteins stability, activity and subcellular localization, but it cannot be 
excluded that CK1γ may also be involved in post-translational regulation of PER proteins.
Thus the aim of this study was to assess the frequency of allelic variants at two PER3 polymorphic sites in a 
large population of healthy volunteers, and their relationship to diurnal preference, sleep-wake timing and mood. 
In addition, the effect of an 8-day course of morning light administration on behavioural and circadian variables 
in a group of well-characterised PER34/PER34 and PER35/PER35 homozygotes was also studied.
Results
Genotype, diurnal preference and sleep-wake variables. The HÖ questionnaire was completed by 
786 subjects (541 females); average HÖ score was 50.2 ± 10.4 (range: 21–78). Diurnal preference was distrib-
uted as follows: 22 extreme evening (3%), 147 moderate evening (19%), 436 intermediate (55%), 163 moderate 
morning (21%) and 18 extreme morning (2%). HÖ scores were in agreement with daily sleep-wake timing in the 
494 subjects for whom sleep diaries were also available [i.e. wake up time (decimal h): evening types 8.5 ± 1.2 vs. 
intermediate types 7.7 ± 0.7 vs. morning types: 6.9 ± 0.6; ANOVA p < 0.001, each group significantly different 
from all others on post-hoc, with p < 0.001].
Both the VNTR genotype and HÖ questionnaire data were available for 679 individuals (459 females). Of 
these, 271 (39.9%) subjects were PER34/PER34, 97 (14.3%) PER35/PER35 and 311 (45.8%) PER34/PER35.
This population was shown to be in Hardy-Weinberg equilibrium (χ2 = 0.259, DF = 1, p = 0.610, Table 1), with 
no significant differences in genotype distribution between females and males (χ2 = 2.976, DF = 2, p = 0.226). 
The distribution of diurnal preference in relation to VNTR genotype is presented in Table 1. No preferential asso-
ciations between genotype/allele and diurnal preference were observed (Wald test: p = 0.737). This also held true 
when intermediate types were excluded and when extreme morning/morning types and extreme evening/evening 
types were pooled (Cochran-Armitage test χ2 = 0.069, p = 0.793).
Subjects with available VNTR genotype (and available, residual DNA) plus diurnal preference data were 
selected for SNP rs228697 genotype determination, based on their diurnal preference score. Morning/extreme 
morning and evening/extreme evening types were selected (i.e. intermediate types were excluded) to maximise 
the likelihood of detecting an association, if any, between the PER3G and PER3C variants and diurnal prefer-
ence. All required data were available for n = 103 morning/extreme morning types and n = 106 evening/extreme 
evening types. This population was also shown to be in Hardy-Weinberg equilibrium (χ2 = 0.248, DF = 1, 
p = 0.618), with no significant differences in SNP genotype distribution between females and males (χ2 = 0.184, 
DF = 2, p = 0.912). The distribution of the combined genotypes of both polymorphic sites is shown in Table 2, 
for morning and evening types separately. Analysis of this sample confirmed the absence of any preferential 
association between the VNTR polymorphism and diurnal preference (Cochran-Armitage test χ2 = 0.467, 
DF = 1, p = 0.494). By contrast, for the SNP rs228697 an association was observed between the PER3G variant 
and morningness (Cochran-Armitage test χ2 = 6.998, DF = 1, p = 0.008, OR = 2.10, 95% CI = 1.21–3.65). Allelic 
co-occurrence at the two sites (Table 2) shows that the PER3G variant was almost in complete linkage disequi-
librium with the PER34 variant (D′ = 0.912). The conditional haplotype test showed a significant association of 
the PER3G-PER34 haplotype with morningness (likelihood ratio χ2 = 8.240, DF = 2, p = 0.016, OR = 2.19, 95% 
CI = 1.17–4.08). This was mostly due to the PER3G association with morningness. Both allelic and haplotypic 
associations remained significant (p < 0.05) after correction for multiple comparisons.
rs57875989
Extreme 
Morning n 
(%)
Morning n 
(%)
Intermediate 
n (%)
Evening n 
(%)
Extreme 
evening n (%) Total n (%) MAF
All
4/4 7 (38.9) 59 (43.7) 142 (38.0) 57 (43.2) 6 (30.0) 271 (39.9) 0.3719
4/5 6 (33.3) 54 (40.0) 183 (48.9) 56 (42.4) 12 (60) 311 (45.8)
5/5 5 (27.8) 22 (16.3) 49 (13.1) 19 (14.4) 2 (10) 97 (14.3)
Females
4/4 6 (46.1) 45 (47.4) 104 (39.5) 40 (44.9) 3 (27.3) 198 (42.0) 0.3599
4/5 4 (30.8) 34 (35.8) 126 (47.9) 37 (41.6) 6 (54.5) 207 (43.9)
5/5 3 (23.1) 16 (16.8) 33 (12.6) 12 (13.5) 2 (18.2) 66 (14.0)
Males
4/4 1 (20.0) 14 (35.0) 38 (34.2) 17 (39.5) 3 (33.3) 73 (35.1) 0.3990
4/5 2 (40.0) 20 (50.0) 57 (51.3) 19 (44.2) 6 (66.7) 104 (50.0)
5/5 2 (40.0) 6 (15.0) 16 (14.5) 7 (16.3) 0 (0.0) 31 (14.9)
Table 1. PER3 genotypes at rs57875989 and minor allele frequencies, by diurnal preference. MAF: Minor Allele 
Frequency. No preferential associations between genotype/allele and diurnal preference were observed (Wald 
test: p = 0.737). This held true also when intermediate types were excluded and extreme morning/morning 
types and extreme evening/evening types were pooled (Cochran-Armitage test χ2 = 0.069, p = 0.793).
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Individuals with one or two PER3G alleles woke up significantly earlier, tended to sleep less and reported 
significantly worse sleep quality compared to their PER3C/PER3C counterparts (diaries available for 117 subjects; 
Table 3). However, these differences were not significant after correction for multiple comparisons (FDR adjusted 
p > 0.05). Although sample numbers became small, individuals with two PER3G alleles (n = 5) tended to exhibit 
even earlier sleep-wake times than their counterparts with one or no PER3G alleles [i.e. wake up time (deci-
mal h): 6.8 ± 0.8 (two PER3G alleles) vs. 7.7 ± 1.5 (one PER3G allele) vs. 8.2 ± 1.2 (no PER3G alleles), p = 0.057]. 
Individuals with any degree of PER3G - PER34 association (i.e. heterozygotes or homozygotes for the PER3G 
together with one or two PER34) woke up significantly earlier, slept less and reported worse sleep quality com-
pared to their counterparts without the association (Table 3). However, these differences were not significant after 
correction for multiple comparisons (FDR adjusted p > 0.05).
The KSS and mood scales were completed by 388 subjects (36%, 278 females). Sleepiness showed significant 
variation over the waking hours of the day, and there was a significant interaction genotype*time for the VNTR 
polymorphism (n = 331). In particular, PER35/PER35 subjects (n = 59) were less sleepy in the morning and more 
sleepy in the early afternoon/early evening compared to their PER34/PER34 (n = 135) and PER34/PER35 (n = 137) 
counterparts (genotype: p = 0.195, time: p < 0.001, genotype*time: p = 0.029; post hoc significant at several time 
points; Fig. 1). There was no significant relationship between KSS scores and the SNP alone or in combina-
tion with the VNTR polymorphism (n = 72). Self-rated mood also showed significant variation over the waking 
hours of the day but no significant association with either polymorphism alone (n = 331 for the VNTR poly-
morphism and n = 72 for the SNP, respectively). However, when the PER3G - PER34 association was considered, 
there was a significant interaction between genotype and mood, individuals with the association (n = 19) having 
rs228697 rs57875989
Morning 
(n = 103) MAF(G) MAF(5)
Evening 
(n = 106) MAF(G) MAF(5)
Total 
(n = 209) MAF(G) MAF(5)
G/G 4/4 0.058 0.204 0.340 0.000 0.108 0.373 0.029 0.155 0.356
C/G 4/4 0.184 0.085 0.134
C/C 4/4 0.223 0.302 0.263
G/G 4/5 0.000 0.000 0.000
C/G 4/5 0.107 0.123 0.115
C/C 4/5 0.282 0.358 0.320
G/G 5/5 0.000 0.000 0.000
C/G 5/5 0.000 0.009 0.005
C/C 5/5 0.146 0.123 0.134
Table 2. Genotypes and minor allele frequencies at the two PER3 polymorphic sites, by diurnal preference. 
MAF: Minor Allele Frequency. G, C and 4, 5 refer to the alleles at rs228697 and rs57875989, respectively. The 
PER3G allele (rs228697) was significantly more represented in morning types (OR = 2.10, p = 0.008). Genotypes 
at the two sites showed an almost complete linkage disequilibrium between the PER3G and PER34 (rs57875989) 
alleles (D′ = 0.912). This PER3G - PER34 haplotype also showed a significant association with morningness 
(OR = 2.19, p = 0.016).
PER3G Present 
(n = 33)
PER3G Absent 
(n = 84)
PER3G - PER34 
Present (n = 32)
PER3G - PER34 
Absent (n = 85)
Bed time (decimal h) 24.0 ± 1.5 24.3 ± 1.3 24.1 ± 1.5 24.3 ± 1.3
Time to fall asleep 
(min) 16.0 ± 11.9 13.2 ± 10.5 16.4 ± 12.0 13.1 ± 10.5
Sleep onset (decimal 
h) 24.6 ± 1.6 24.9 ± 1.3 24.7 ± 1.5 24.8 ± 1.4
Awakenings (n) 0.9 ± 1.0 0.8 ± 0.7 0.9 ± 1.1 0.8 ± 0.7
Wake up time 
(decimal h) 7.6 ± 1.4* 8.2 ± 1.2 7.6 ± 1.4 * 8.1 ± 1.2
Get up time (decimal 
h) 8.0 ± 1.4 8.5 ± 1.2 8.0 ± 1.4 8.5 ± 1.2
Naps (n) 0.1 ± 0.2 0.2 ± 0.3 0.1 ± 0.2 0.2 ± 0.2
Length of sleep (h) 6.9 ± 0.9 7.3 ± 0.8 6.9 ± 0.8* 7.3 ± 0.8
Sleep efficiency (%) 87.5 ± 8.7 89.2 ± 7.0 87.3 ± 8.8 89.3 ± 7.0
Sleep quality (1–10 
scale) 4.2 ± 1.5* 3.7 ± 1.3 4.2 ± 1.5* 3.7 ± 1.3
PSQI global score 
(0–21)° 6.9 ± 4.2* 5.4 ± 2.9 7.1 ± 4.2* 5.4 ± 2.9
Table 3. Sleep-wake timing and sleep quality indices in relation to the presence/absence of the PER3G allele and 
the PER3G - PER34 association. *p < 0.05 on direct comparisons, not confirmed after correction for multiple 
comparisons (FDR adjusted p > 0.05). °Data available for 37/90 participants with/without the PER3G allele and 
for 36/91 participants with/without the PER3G - PER34 association. PSQI: Pittsburgh Sleep Quality Index.
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a significantly worse mood in the early evening hours compared to those without (n = 53) (genotype: p = 0.756, 
time: p = 0.045, genotype*time: p = 0.020; post hoc significant from 18:30 to 21:30 h; Fig. 2).
Response to light. No significant differences were observed in sleep timing and/or aMT6s rhythms between 
PER34/PER34 and PER35/PER35 individuals at baseline (Table 4). After light administration, 15 subjects (12 
PER34/PER34, 3 PER35/PER35) showed an advance in their aMT6s acrophase, 3 a delay in aMT6s acrophase (all 
PER35/PER35) and 12 no significant change (7 PER34/PER34, 5 PER35/PER35). Thus, when the direction of phase 
shift was accounted for, significant differences were observed between the response to light in the two genotypes, 
with PER34/PER34 subjects advancing their aMT6s acrophase by approximately half an hour compared to their 
Figure 1. Karolinska Sleepiness Scale scores (1–9, with 9 = maximum sleepiness; mean ± 95% CI) over the 
waking hours of the day in PER35/PER35 (black circles, n = 59), PER34/PER35 (light grey squares, n = 137) 
and PER34/PER34 (dark grey diamonds, n = 135) subjects. Effect of genotype: p = 0.195, time: p < 0.001, 
genotype*time: p = 0.029.
Figure 2. Mood scores (1–10 scale, 10 = best; mean ± 95% CI) over the waking hours of the day in individuals 
with (grey squares, n = 19) and without (black circles, n = 53) the PER3G - PER34 association. Effect of genotype: 
p = 0.756, time: p = 0.045, genotype*time: p = 0.020. *Post hoc significant with p < 0.05 at 19:30 h and 20:30 h, 
p < 0.01 at 18.30 h and 21:30 h.
Sleep diary variables Urinary aMT6s rhythm cosinor indices
Sleep onset 
(clock time, 
h:min)
Wake-up 
(clock time, 
h:min)
Awakenings 
(n)
Mesor (pg/
ml)
Amplitude 
(pg/ml)
Achrophase 
(clock time, 
h:min)
PER34/PER34 
(n = 19)
00:49 ± 01:12 
(23:03–03:52)
07:39 ± 01:16 
(05:46–10:39)
1.0 ± 0.9 
(0.0–4.3)
13.91 ± 6.55 
(3.52–
26.47)
18.76 ± 8.85 
(5.37–35.84)
04:45 ± 01:31 
(02:12–07:11)
PER35/PER35 
(n = 11)
00:33 ± 01:06 
(22:55–02:25)
07:49 ± 00:51 
(06:29–08:54)
1.2 ± 0.8 
(0.3–2.3)
12.10 ± 6.92 
(4.47–
28.67)
15.68 ± 10.28 
(4.00–39.39)
04:14 ± 01:02 
(02:04–05:30)
Table 4. Baseline sleep diary and urinary aMT6s rhythm indices, by genotype. Data are expressed as 
mean ± SD (range). aMT6s: 6-sulphatoxymelatonin.
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PER35/PER35 counterparts (−26 ± 32 vs. +3 ± 43 min; p = 0.037; Fig. 3). Absolute value changes (i.e. not taking 
into account of their direction) were comparable in the two groups (30 ± 29 min in PER34/PER34 participants vs. 
30 ± 30 min in PER35/PER35 participants). No significant changes were observed in other aspects of the aMT6s 
rhythms (mesor, amplitude, total amount produced) in relation to light administration.
PER34/PER34 subjects (n = 19) also exhibited a trend (0.05 < p < 0.1) for a stronger response to light in terms 
of an earlier sleep onset and wake up times after light administration compared to their PER35/PER35 counter-
parts (n = 11). In both PER34/PER34 and PER35/PER35 groups, the course of light treatment significantly reduced 
the number of awakenings (from approximately 1 per night to 0.5 per night; genotype: p = 0.194, time: p = 0.003, 
genotype*time: p = 0.694).
While the SNP was only available in 12 individuals who underwent light administration and statistical power 
was insufficient for a full analysis, the tendency for individuals with any degree of PER3G - PER34 association (one 
or two PER3G together with one or two PER34, n = 3 out of the 12 available) to show earlier wake-up times and an 
earlier aMT6s acrophase was confirmed.
Discussion
This is the first study carried out in a large, healthy population of Caucasian individuals living in Northern Italy 
regarding the relationship of two clock gene PER3 polymorphic sites (the rs228697 SNP and the PER34-PER35 
rs57875989 VNTR polymorphism) and a set of sleep-wake phenotypes, including diurnal preference, sleep-wake 
timing and mood.
While several studies have implicated the Period genes PER1 and PER2 in the molecular timekeeping of 
the master circadian clock, the role of PER3 is less clear. In a study assessing PER1-promoter-driven luciferase 
expression in cultured suprachiasmatic nuclei (SCN), pituitary, and lung explants from PER2−/− and PER3−/− 
mice, Pendergast et al.13 observed that the period of PER1-luc expression in PER2−/− SCN explants was 1.5 hours 
shorter than that of PER2+/+. In the same study, PER3−/− and PER3+/+ mice exhibited comparable SCN explants, 
while the period/phase of their pituitary and lung explants were different, and were abnormal in PER3−/−. These 
observations suggest that the function of each PER gene may be tissue-specific. In a subsequent study, Pendergast 
et al.14 observed shortening of periods in some peripheral tissues but not in the SCN of PER3−/− mice compared 
to wild-types. Such period shortening resulted in advanced phases, indicating that some degree of internal mis-
alignment may occur in PER3−/− mice. Based on the circadian features/light sensitivity of both PER3−/− mice and 
rare PER3 polymorphic variants, Zhang et al.15 have recently hypothesised that PER3 may affect the clock via a 
stabilising function on PER1/PER2.
In the present study, no relationship was observed between the PER34 – PER35 VNTR polymorphism and 
diurnal preference. The available literature is conflicting in this respect, with at least three studies documenting 
this association7, 16, 17 and others failing to replicate it18–20. Several factors could explain these discrepancies. For 
example, Pereira and colleagues16 have suggested that latitude may be implicated, together with differences in the 
length of days, climate and temperature variations throughout the year. However, two of the conflicting studies 
were based in the United Kingdom, thus on populations sharing similar environmental conditions7, 18. It is rea-
sonable that the diurnal preference phenotype might be multifactorial in origin, with genetic factors being more 
or less obvious depending on the features of the population, and the varying weight of other factors.
Melatonin production, subjective sleepiness and waking slow electroencephalographic activity are reduced 
by the exposure to 460 nm blue monochromatic light during the biological night21, 22. Such light responses have 
been reported to be stronger in PER35/PER35 compared to PER34/PER34 healthy subjects8, thus it has been sug-
gested that PER3 variants may contribute to the inter-individual variability of the non visual responses to light8. 
All protocols testing such a hypothesis have been performed within the context of light-induced suppression 
of nocturnal melatonin production8, 21, with administration of light at night. In the clinical/therapeutic setting, 
however, bright light is often used to advance circadian phase, and is thus delivered at the beginning of the day23. 
Hence our attempt to test light responses in relation to genotype in the setting of morning light administration. 
In our study, despite large within group variability, morning light showed more prominent phase shifting effects 
Figure 3. 6-sulfatoxymelatonin (aMT6s) acrophase in the PER34/PER34 (light grey, n = 19) and PER35/PER35 
(dark grey, n = 11) subjects, before and after light administration. Effect of genotype: p = 0.646, time: p = 0.101, 
genotype*time: p = 0.037.
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in PER34/PER34 compared to PER35/PER35 subjects. This is reasonable, as supplementation of morning light may 
be more effective in individuals who are intrinsically less sensitive to light (PER34/PER34 subjects8) and thus less 
likely to have already benefited from the alerting effect of getting up and being exposed to standard room lighting 
in the early morning. This interpretation is supported by our data on the time-course of subjective sleepiness in 
PER35/PER35 versus PER34/PER34 subjects. Interestingly, all three subjects who showed a somewhat paradoxical 
response to morning light, delaying their aMT6s acrophase, were PER35/PER35, in line with previous findings on 
light sensitivity in this group8. Morning light supplementation reduced the number of night awakenings in all 
treated subjects, confirming its sleep consolidating effects9. These data are clinically relevant as they could help: i) 
understanding blunted and excessive/paradoxical responses to light administration; ii) refining patient selection 
and monitoring during a course of chronotherapy.
In this study, we observed a novel, strong association between the PER3G allele (rs228697 SNP) and morning-
ness, and an even stronger one between the PER3G - PER34 haplotype and morningness. This was confirmed by 
daily sleep diaries, which documented earlier sleep onset (trend) in PER3G and PER3G - PER34 subjects. However, 
these differences were not significant after correction for multiple comparisons. Our findings contrast, to some 
extent, with those of Hida and colleagues11, who documented a weak albeit significant association between the 
PER3G allele and eveningness. Interestingly, and despite large within group variability, in our study PER3G - PER34 
subjects also showed a different time-course of their mood over the waking hours, with significantly lower mood 
scores in the late afternoon/early evening. Rare PER3 variants have previously been linked to depressive behav-
iour both in humans with advanced sleep phase syndrome and in a mouse model mimicking rare PER3 human 
mutations15. In addition, progressive worsening of mood has been documented over the waking hours of the day 
in humans24. This may of course be modulated by diurnal preference.
Haplotype frequency pattern analysis (Table 2) suggests a tentative parsimonious phylogeny relationship 
accounting for the origin of the four haplotypes. We hypothesize that PER3G - PER34 and PER3C - PER34 hap-
lotypes could be the ancestral ones, and that the 4-units to 5-units expansion of the repeated region occurred 
on a PER3C - PER34 background, thus originating the PER3C - PER35 haplotype. A very low recombination rate 
between the PER3C - PER35 and PER3G - PER34 haplotypes, due to the very small distance between the two poly-
morphic sites (2348 base pairs), could thus explain the almost complete absence of the PER3G - PER35 haplotype. 
Interestingly, the carrier and estimated haplotype frequencies for the rs228697 and rs57875989 polymorphisms 
described by Ebisawa and colleagues6 reflect the distribution observed in this study, with no PER3G - PER35 
association.
The association between the PER3G - PER34 haplotype and morningness could reflect the specific effects of 
the PER3A variant on the circadian molecular cycle. As pointed out by Hida and colleagues11, the P864A amino 
acid substitution affects the hydropathy index of the protein, altering its secondary structure and its phosphoryl-
ation dynamics. Indeed, the substitution could disrupt two potential SH3-binding domains [(LPDPP-864) and 
(PP-864-VCP)] which could, in turn, impinge on the interaction between PER3 and NCK. NCK is a scaffolding 
protein with SH3 domains which has been implicated in the PER3 interaction with a CKI. Such interaction regu-
lates PER accumulation/stability throughout the circadian cycle12. In this scenario, it can be hypothesised that the 
PER3A protein is more stable and accumulates faster in the cytoplasm compared to the PER3P. Therefore, PER3A 
is likely to enter the nucleus earlier than PER3P to exert a negative feedback on the transcription of PER and CRY 
genes. This would result in shorter periodicity in free running conditions, and phase advancing of some circa-
dian phenotypes, which fits with our observed association between the ‘faster accumulating’ PER3A protein and 
morningness. While PER3 appears to affect mainly peripheral clocks13, 14, it cannot be excluded that at least some 
of these effects may feedback to the SCN, contributing to the modulation of the phase of sleep timing. Based on 
experiments in primary dermal cells, Brown et al.2 suggested that human diurnal preference may be influenced by 
cellular components that affect the amplitude and phase of the circadian oscillator. Ferrante et al.25 observed that 
PER3 circadian expression in a peripheral tissue (hair follicle) of morning types was 1.5 hours earlier than that of 
intermediate types, and 3 hours earlier than that of evening-types. If our hypothesis of the effects of the P864A 
polymorphism on the molecular mechanisms underlying the oscillation is correct, a 2–3 hour phase difference in 
peripheral clocks in PER3C and PER3G bearing individuals could modulate the phase of their sleep.
The contribution of the PER34 VNTR variant, albeit modest, in association with PER3G in defining a morning 
phenotype is also in line with the proposed model, because the number of putative phosphorylation sites situated 
on the repeats are fewer in PER34 compared to PER35. This could result in faster cytoplasm accumulation kinetics 
and, in turn, in negative feedback and phase advancing. It is possible that this may also affect the sensitivity to 
light. Indeed, it has been demonstrated that light induces a larger phase delay (or smaller phase advance) in dif-
ferent, rare human PER3 variants, which results in abnormal entrainment15.
Of the five non synonymous SNPs which Ebisawa and colleagues originally implicated in the pathogenesis of 
delayed sleep phase syndrome6, one (rs10462020, which causes a V674G substitution) has also been associated 
with diurnal preference by Johansson and colleagues26. Another one (rs2640909) causes a M1037T substitution, 
which alters the hydrophobicity of the PER3 protein, possibly affecting PER3 auto-feedback27. This polymor-
phism was associated with morningness by Ojeda and colleagues27 but not by Hida and colleagues11.
In conclusion, significant associations were observed between the PER3G polymorphic variant in rs228697 
(alone and in combination with the PER34 variant in rs57875989) and morningness, as well as the course of mood 
over the waking hours of the day.
Methods
Participants. A sample of 786 subjects describing themselves as Caucasian and living in Northern Italy [531 
females, age 28.6 ± 12.5 (range 18–79)] were recruited in Padova, Italy, during popular science events (January 
2012, September 2013 and September 2014). Subjects were excluded if they had significant medical history, any 
chronic disease, or took regular medication, except for oral contraceptives. All volunteers were asked to donate 
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a buccal DNA sample (brushing the internal cheek surface firmly for about 15 seconds with a swab; n = 679 
accepted), and to complete a sleep-wake assessment including diurnal preference [Horne - Östberg questionnaire 
(HÖ questionnaire)28], night sleep quality [Pittsburgh Sleep Quality Index (PSQI)29], Karolinska Sleepiness Scale 
(KSS)30], mood (visual-analogue 1–10 scale) and habitual sleep timing (sleep diaries). The HÖ questionnaire was 
completed during the popular science initiative, with the same researchers providing instructions and answering 
any questions. The remaining questionnaires and diaries were completed by the participants at home, in the sub-
sequent two-three weeks. Addressed, stamped envelopes were provided; 550 (51%) were returned, with partial 
or complete information. Participants who provided a readable, viable e-mail address (98%) were subsequently 
sent a summary report of their sleep-wake assessment and genotype. A brief description of the questionnaires and 
diaries utilized is provided below.
Study protocols were approved by the Padova University Hospital Ethics Committee (Medical Bio-bank 
and 3639/AO/15 for light administration) and conducted according to the Declaration of Helsinki (Hong Kong 
amendment) and good clinical practice (European) guidelines. All methods were performed in accordance with 
the above ethical guidelines and regulations. All participants provided written, informed consent.
Sleep-wake assessment. The HÖ questionnaire was used to assess diurnal preference. The total score 
ranges from 16 to 86: scores <41 define evening (extremely evening <30) types, scores ≥59 define morning 
(extremely morning ≥70) types, and scores between 42 and 58 intermediate types28.
The PSQI was used to assess night sleep quality over the preceding month. Questionnaire responses generate 
seven components (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep distur-
bances, use of sleeping medication, and daytime dysfunction), which are summated to provide the PSQI global 
score (range: 0–21); scores of >5 identify ‘poor’ sleepers29, 31.
The KSS was used to assess daytime sleepiness. Participants rated their subjective sleepiness over the previ-
ous 10 minutes, from 1 (very alert) to 9 (very sleepy, fighting sleep, difficulty staying awake)30. In this particular 
instance, participants were provided with a set of KSS sheets and asked to complete them on an hourly basis over 
the waking hours of a typical working/studying day, from get-up to bed-time.
Mood visual-analogue scale sheets were also provided (“Please rate your mood from 1–10 on this scale”, with 
10 being marked as best) and participants asked to complete them on an hourly basis over the waking hours of a 
typical working/studying day, from get-up to bed-time32.
Sleep diaries were completed daily that included a record of bed-time, sleep onset, time to fall asleep, wake-up 
time, get-up time, number/duration of any night awakenings or daytime naps. Relevant metrics were calculated, 
including sleep onset latency, wakefulness after initial sleep onset, total sleep time, total time spent in bed, sleep 
efficiency (time asleep out of total time in bed, as a percentage), and a subjective appraisal of each night’s sleep 
quality (1–10, with 10 being the negative extreme)33. Participants were instructed to complete the sleep diary each 
morning, after every night sleep, for 12 days, to include a week-end. Sleep diaries were also completed during the 
light administration protocol (vide infra) and sleep data were considered both singly and as averages pre- (study 
days 2–4, Tuesday to Thursday) and during light administration (study days 9–11, also Tuesday to Thursday).
Genotyping. PER34 – PER35 VNTR (Genoma, Build GRCh38, chrom1, start 7829867). Genotyping was per-
formed using polymerase chain reaction (PCR) with the primers described by Ebisawa et al.6 (Supplementary 
Table 1). The polymerase mixture was prepared in a 20 µl final volume and was composed of 10.6 μl sterile water; 
4 µl 5X Taq buffer; 1 μl of 10 mM dNTPs mix; 1 μl of 10 µM Reverse primer; 1 μl of 10 µM Forward primer; 2 μl 
Genomic DNA; and 2U of GoTaq DNA Polymerase (Promega). The amplification conditions were: 94 °C for 
3 minutes, then 30 cycles of 94 °C for 1 minute, 55 °C for 1 minute, 72 °C for 1 minute and a final elongation of 
72 °C for 10 minutes. Agarose gel electrophoresis was used to identify whether individuals were heterozygous or 
homozygous for either of the PER3 repeat alleles. For the subgroup of 209 subjects who were also genotyped for 
SNP rs228697 (vide infra), genotyping by gel electrophoresis was validated by GeneScan analysis by using the 
same primer pair proposed by Ebisawa et al.6 but with a HEX-labelled version of the forward primer. Detailed 
primer sequences are listed in Supplementary Table 1. A negative and two positive controls (PER34 and PER35) 
were included in each test performed.
SNP rs228697 (C/G− > P/A) (Genoma, Build GRCh38, chrom1, 7827519). The detection of the C2590G (P864A) 
polymorphism was performed by a double fluorescent tetra-primer amplification refractory mutation system 
PCR (dF-T-ARMS-PCR)34. Two allele-specific primer pairs were designed according to the requirements of the 
df-T-ARMS-PCR protocol. The specificity of each allele-specific primer is conferred by the identity of the ter-
minal 3′ nucleotide with one of the two possible single nucleotide variations. The two different fluorescent dyes 
(FAM and HEX) used to specifically label the two allele-specific primer pairs, as well as the significantly different 
length of their amplicons, allowed for easily distinguishable signals by GeneScan analysis (Peak Scanner Software 
v1.0; Thermo Fisher Scientific). Primer sequences are detailed in Supplementary Table 1. PCR was performed in 
a 50 µl final volume and was composed of 27.6 μl sterile water; 10 µl 5X Taq Buffer; 1 μl of 10 mM dNTPs mix; 1 μl 
of 10 µM Forward and Reverse primers; 5 μl Genomic DNA; and 2U GoTaq DNA Polymerase (Promega). The 
thermal cycling conditions were as follows: 2 minutes denaturation at 95 °C, followed by 35 cycles of 15 seconds 
denaturation at 95 °C, 20 seconds annealing at 57 °C, 1 minute elongation at 72 °C, and a final 3-min elongation 
cycle at 72 °C. Capillary electrophoresis was performed with an ABI 3100 Genetic Analyzer (Applied Biosystems) 
at BMR Genomics (Padova, Italy). The size of the products was determined using the GeneScan 400HD ROX size 
standard (Thermo Fisher). A negative and two positive controls (PER3C and PER3G) were included in each test 
performed.
www.nature.com/scientificreports/
8Scientific RepoRts | 7: 6967  | DOI:10.1038/s41598-017-06769-w
Morning light administration protocol. A subgroup of 30 subjects who were homozygous for the length 
polymorphism [19 PER34/PER34 (27 ± 9 yrs, 15 females) and 11 PER35/PER35 (26 ± 10 yrs, 8 females)] underwent 
a course of morning light administration, whilst monitoring sleep-wake patterns and melatonin rhythmicity.
Experimental design. The study was conducted over 12 days and sleep-wake diaries completed daily (Table 5). 
The KSS was completed hourly over the waking hours of days 1 (pre-light) and 11 (end of light) (Table 5). Two 
separate 56-hour urine collections (over 2 days and 3 nights, at 4 hour intervals during the day and 8 hour inter-
vals at night) were obtained on study days 1–3 (pre-light) and 9–11 (end of light) (Table 5) for assessment of the 
urinary melatonin metabolite 6-sulfatoxymelatonin (aMT6s; vide infra) rhythms. Participants were provided with 
a Light Box (SAD3 10000 lux - E.M.S. srl Bologna, Italy) and instructed to expose themselves to light daily for 
45 minutes, immediately after getting-up. They were asked to place the Light Box at approximately 60 cm from 
their head, to one side, and to direct their gaze at the Light Box every 10–15 minutes. If they moved away from the 
box (for example to go to the toilet or get dressed) they were instructed to make up the lost time at the end of the 
session. During the entire study period, subjects were asked to maintain regular sleep-wake schedules and avoid 
significant changes to their habitual consumption of coffee, tea, chocolate and alcoholic beverages. They were also 
asked to avoid exposure to very bright light and use of mobiles/tablets in the evening and at night. Compliance 
was checked by phone every third day by one of the researchers.
6-sulfatoxymelatonin (aMT6s) assessment. Urinary samples were kept at −20 °C and aMT6s concentrations 
measured by radioimmunoassay (Stockgrand Ltd.). Urine samples were analyzed in duplicate and all samples 
from the same subject were included in the same assay. The inter-assay coefficients of variation (CVs) were 13.3% 
at 2.4 ng/mL, 8.9% at 10.4 ng/mL, and 15.4% at 17.5 ng/mL (n = 16 at each concentration).
The aMT6s rhythms were evaluated using cosinor analysis, which is based on the least square approximation 
of the time series using a cosine function with a period of 24 hours35. The following parameters were obtained: 
acrophase time (time of peak aMT6s concentration, or maximum of the fitted cosinor function), mesor (mean 
aMT6s value for all the samples included in the cosinor analysis) and amplitude (difference between the mesor 
and the peak aMT6s concentrations). Data were considered acceptable if the cosinor fit, or the likelihood of 
the data points fitting a cosine curve as opposed to a straight line, was significant at the 95% level (p < 0.05)36. 
All parameters were assessed both pre- and post-light administration and the difference in aMT6s acrophase 
(peak) time between the pre- and post-light administration was also computed and considered significant when 
>15 min.
Statistical Analysis. Data are presented as mean ± standard deviation (SD) or 95% Confidence Interval 
(CI). Clock times are presented as decimal hours (h) within the results section, and as h:mins in Tables and 
Figures, to facilitate reading, where possible.
Hardy-Weinberg equilibrium was tested by the Pearson χ2. Association testing between single polymorphisms 
and diurnal preference was performed using the Cochran-Armitage test (PLINK open-source whole genome 
association analysis toolset; http://pngu.mgh.harvard.edu/purcell/plink/)37. Haplotypic testing was conducted 
using the conditional haplotype-based test module, also on PLINK, which estimates haplotypes to be tested from 
unphased genotypes. Experiment-wide correction for multiple testing was applied (FDR method, n = 3 tests).
The Student t/Mann-Whitney U test (correction for multiple testing applied where appropriate) and ANOVA/
Kruskal-Wallis ANOVA were used to compare sleep-wake variables between two and multiple groups, as appro-
priate (post-hoc: Tukey/multiple comparisons of mean ranks). Repeated measures ANOVA was utilized to 
assess the time-course of variables and/or their changes in relation to light administration (post-hoc: Tukey test) 
(Statistica 13.1, Dell. Round Rock, Texas, US). As hourly KSS/mood data were available for most subjects in the 
time slot between 9:30 and 21:30 h (at earlier/later times, the numbers decreased significantly), this was the time 
interval utilized for analysis.
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